+61 2 9894 6811 info@iap-aus.org.au

Division News

Queen’s Birthday 2019 Honours List

Jane Esther Dahlstrom (ACT)

For service to medical education, and to pathology

Born and raised in Sydney Australia, Jane Dahlstrom is a medical graduate of the University of Sydney, Australia. After completing her PhD at the John Curtin School of Medical Research at the Australian National University (ANU) she entered speciality training in Anatomical Pathology. She is a Fellow of the Royal College of Pathologists of Australasia (RCPA) in Anatomical Pathology and in Oral Pathology and is a founding Fellow of the Faculty of Science of RCPA. Jane was admitted as a Senior Fellow of the Higher Education Academy (SFHEA) in 2014.

Jane is passionate about assisting pathologists from underserved regions of the world. Being chair of the Education Committee of International Academy of Pathology (IAP), President of the Australasian Division of the IAP, immediate past Vice President Asia-Pacific of IAP and immediate past president of the International Paediatric Pathology Association (IPPA) has enabled her to help promote collaborative educational activities of pathologists within these regions.

Jane has a keen interest in medical education and has won multiple institutional and national awards for her teaching. Her research basis is both clinical and experimental including areas of breast, perinatal and developmental pathology.

Jane is currently Executive Director of ACT Pathology, Canberra Health Services, Senior Staff Specialist in Anatomical Pathology at ACT Pathology and Chair and Professor of Pathology, ANU Medical School, College of Health and Medicine at ANU.


‘NSW Premier’s ‘Professor Rob Sutherland AO Make a Difference Award’

Congratulations to Professor Richard Scolyer at Melanoma Institute Australia, Royal Prince Alfred Hospital and The University of Sydney who was awarded the NSW Premier’s ‘Professor Rob Sutherland AO Make a Difference Award’. 

Professor Scolyer is the world’s most highly cited melanoma pathologist and co-leads a world-renowned translational research laboratory. His ground-breaking work in the diagnosis and prognostic markers of melanoma, the genetic characterisation of melanoma (he co-leads the Australian Melanoma Genome Project), cancer staging, and the rapid detection of the BRAF mutation by immunohistochemistry has made a real difference to the management and survival of patients with melanoma worldwide. 

His leading work on the classification of skin cancers (recognised with the appointment as an editor for 4th Edition of World Health Organisation Classification of Skin Tumours) and staging (he is Vice Chair for Melanoma Expert Panel for the AJCC Cancer Staging System) has had an impact across the world. He has presented on >300 occasions at international conferences, and is a co-author of more than 500 articles and book chapters including publications in New England Journal Medicine, Lancet and Nature.


Richard also won the GSK Award for Research Excellence along with Professor Georgina Long for their exceptional contribution to medical research that has transformed melanoma treatment and patient care.